Srinivas Sridhar
Affiliations: | Physics | Northeastern University, Boston, MA, United States |
Area:
General Physics, Electricity and Magnetism Physics, NanoscienceGoogle:
"Srinivas Sridhar"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Evin Gultepe | grad student | 2010 | Northeastern University |
| Yongjian Huang | grad student | 2011 | Northeastern University |
| Dattatri K. Nagesha | post-doc | (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kunjachan S, Detappe A, Kumar R, et al. (2020) Correction to "Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy". Nano Letters |
| Mueller R, Yasmin-Karim S, DeCosmo K, et al. (2020) Increased carcinoembryonic antigen expression on the surface of lung cancer cells using gold nanoparticles during radiotherapy. Physica Medica : Pm : An International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (Aifb). 76: 236-242 |
| Virani NA, Kelada OJ, Kunjachan S, et al. (2020) Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption. Plos One. 15: e0236245 |
| Schuemann J, Bagley A, Berbeco R, et al. (2020) Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions. Physics in Medicine and Biology |
| Cheng MJ, Mitra R, Okorafor CC, et al. (2020) Targeted Intravenous Nanoparticle Delivery: Role of Flow and Endothelial Glycocalyx Integrity. Annals of Biomedical Engineering |
| Kunjachan S, Kotb S, Pola R, et al. (2019) Selective Priming of Tumor Blood Vessels by Radiation Therapy Enhances Nanodrug Delivery. Scientific Reports. 9: 15844 |
| Zhang D, Baldwin P, Leal AS, et al. (2019) A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice. Theranostics. 9: 6224-6238 |
| Baldwin P, Ohman AW, Medina JE, et al. (2019) Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model. Frontiers in Oncology. 9: 353 |
| Kelada OJ, Kunjachan S, Virani NA, et al. (2019) Abstract 85: Noninvasive imaging of tumor hypoxia during radiation-induced tumor vascular disruption Cancer Research. 79: 85-85 |
| Singh B, Abdelhalim M, Warrington S, et al. (2019) Abstract 3631: Development of targeted nanoformulation of talazoparib for combined chemoradiation therapy in lung cancer Cancer Research. 79: 3631-3631 |